Cargando…
Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice
We reported previously that intranasal instillation of a synthetic human pulmonary surfactant with a carboxy vinyl polymer as a viscosity improver, named SF-10, shows potent adjuvanticity for humoral immunity in mice and cynomolgus monkeys. SF-10 effectively induces influenza hemagglutinin vaccine (...
Autores principales: | Kim, Hyejin, Kimoto, Takashi, Sakai, Satoko, Takahashi, Etsuhisa, Kido, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784949/ https://www.ncbi.nlm.nih.gov/pubmed/29370185 http://dx.doi.org/10.1371/journal.pone.0191133 |
Ejemplares similares
-
Induction of systemic, mucosal, and cellular immunity against SARS‐CoV‐2 in mice vaccinated by trans‐airway with a S1 protein combined with a pulmonary surfactant‐derived adjuvant SF‐10
por: Kimoto, Takashi, et al.
Publicado: (2023) -
Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF‐10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses
por: Kimoto, Takashi, et al.
Publicado: (2013) -
A Murine Model of Food Allergy by Epicutaneous Adjuvant-Free Allergen Sensitization Followed by Oral Allergen Challenge Combined with Aspirin for Enhanced Detection of Hypersensitivity Manifestations and Immunotherapy Monitoring
por: Kameda, Keiko, et al.
Publicado: (2023) -
Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity
por: Takahashi, Etsuhisa, et al.
Publicado: (2023) -
Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D
por: Hartshorn, Kevan L, et al.
Publicado: (2008)